Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2012
05/10/2012US20120115235 Enhanced cellulase expression in s. degradans
05/10/2012US20120115234 Down-regulation of gene expression using artificial micrornas
05/10/2012US20120115233 Leafhopper Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof
05/10/2012US20120115232 Method for inducing degradation of protein in mammalian cell
05/10/2012US20120115231 Novel lysophospholipid acyltransferase
05/10/2012US20120115229 Embryonic stem cells and neural progenitor cells derived therefrom
05/10/2012US20120115228 Oligomeric compounds and compositions for the use in modulation of micrornas
05/10/2012US20120115227 Gene transfer vectors comprising genetic insulator elements and methods to identify genetic insulator elements
05/10/2012US20120115220 Anti-MicroRNA Oligonucleotide Molecules
05/10/2012US20120115219 High affinity binding site of HGFR and methods for identification of antagonists thereof
05/10/2012US20120115208 Modular method for rapid assembly of dna
05/10/2012US20120115207 Enhanced production of papillomavirus-like particles with a modified baculovirus expression system
05/10/2012US20120115205 Botulinum Neurotoxin Serotype B Activatable Botulinum Neurotoxin Serotype Bs
05/10/2012US20120115203 Method for producing 4-hydroxy-l-isoleucine
05/10/2012US20120115202 Photocatalytic hydrogen production in cyanobacteria
05/10/2012US20120115188 Chimeric dna polymerases
05/10/2012US20120115186 Fermentative production of ethanol from glucose, galactose and arabinose employing a recombinant yeast strain
05/10/2012US20120115164 Mammalian cytokines; related reagents
05/10/2012US20120115156 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
05/10/2012US20120115151 Method for testing a subject thought to be predisposed to having metastatic cancer using delta133p53beta
05/10/2012US20120115136 Pna diagnostic use
05/10/2012US20120115134 Methods for diagnosis and prognosis of cancer
05/10/2012US20120114799 Polypeptides Having Phytase Activity and Polynucleotides Encoding Same
05/10/2012US20120114759 Peptide/particle delivery systems
05/10/2012US20120114744 Compositions and methods to treat muscular & cardiovascular disorders
05/10/2012US20120114708 Integrin heterodimer and an alpha subunit thereof
05/10/2012US20120114700 Lat adapter molecule for enhanced t-cell signaling and method of use
05/10/2012US20120114698 Salmonella marker vaccine
05/10/2012US20120114693 Nucleic acid mucosal immunization
05/10/2012US20120114691 Vaccine against african horse sickness virus
05/10/2012US20120114688 Vaccines comprising non-specific nucleoside hydrolase and sterol 24-c-methyltransferase (smt) polypeptides for the treatment and diagnosis of leishmaniasis
05/10/2012US20120114684 Compounds and methods for treatment and diagnosis of chlamydial infection
05/10/2012US20120114683 Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences
05/10/2012US20120114680 Dendritic Cell Compositions and Methods
05/10/2012US20120114674 Molecular Antigen Array
05/10/2012US20120114672 Antibodies Specific to Cadherin-17
05/10/2012US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
05/10/2012US20120114665 Human antibodies to human rankl
05/10/2012US20120114660 Antibodies Against LLG Polypeptides of the Triacylglycerol Lipase Family
05/10/2012US20120114659 Antibodies for Guanylyl Cyclase Receptors
05/10/2012US20120114657 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of Serotype IATS 01 of Pseudomonas Aeruginosa
05/10/2012US20120114655 Xylan utilization regulon for efficient bioprocessing of hemicellulose and uses thereof
05/10/2012US20120114654 Human antibodies to human tnf-like ligand 1a (tl1a)
05/10/2012US20120114652 Anti-pai-1 antibodies and methods of use thereof
05/10/2012US20120114650 Single chain antibodies against beta-amyloid peptide
05/10/2012US20120114647 anti-serum album single variable domains
05/10/2012US20120114630 Variants of plasminogen and plasmin
05/10/2012US20120114620 Engineered Dendritic Cells and Uses for the Treatment of Cancer
05/10/2012US20120114619 Protein with promoting effects for axonal growth of neurons of central nervous system
05/10/2012US20120114613 Definitive endoderm cell populations
05/10/2012US20120114612 Oncolytic Viruses And Methods For Treating Neoplastic Disorders
05/10/2012US20120114610 Novel endophytic fungi and methods of use
05/10/2012US20120114607 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
05/10/2012CA2854619A1 Methods for producing virus particles with simplified glycosylation of surface proteins
05/10/2012CA2821299A1 Linking sequence reads using paired code tags
05/10/2012CA2818080A1 Densovirus-derived vector for gene transfer in insects
05/10/2012CA2816959A1 Soybean markers linked to scn resistance
05/10/2012CA2816916A1 High amylose wheat
05/10/2012CA2816803A1 Dual variable domain immunoglobulins and uses thereof
05/10/2012CA2816796A1 Preparation of neutralizing antibody to human herpesvirus 6 glycoprotein q1 and analysis thereof
05/10/2012CA2816702A1 Analysis of fragmented genomic dna in droplets
05/10/2012CA2816584A1 Compositions of a peptide-based system for cell-specific targeting
05/10/2012CA2816575A1 A new variant of antihemophilic factor viii having increased specific activity
05/10/2012CA2816352A1 Dsmz 24726 for second generation bioethanol production
05/10/2012CA2816311A1 Gardnerella vaginalis assay
05/10/2012CA2816236A1 Stress-resistant plants and their production
05/10/2012CA2815927A1 Transgenic plants with improved saccharification yields and methods of generating same
05/10/2012CA2815887A1 Plant expression system
05/10/2012CA2815727A1 Modulation of immune responses by the poxviral k4 protein
05/10/2012CA2815430A1 Compositions and methods for production of fermentable sugars
05/10/2012CA2815426A1 Compositions and methods for the generation of platelets and methods of use thereof
05/10/2012CA2815341A1 Methods for increasing yield and fine chemical production in plants
05/10/2012CA2815266A1 Stable heterodimeric antibody design with mutations in the fc domain
05/10/2012CA2814704A1 Methods and vectors for cell immortalisation
05/09/2012EP2450455A1 Method for determining presence or absence of epithelial cancer-origin cell in biological sample, and molecular marker and kit therefor
05/09/2012EP2450451A1 Method for racemizing optically active -amino acids
05/09/2012EP2450448A1 Methods for plant transformation using spectinomycin selection
05/09/2012EP2450447A1 Manipulation of plant senescence using modified promoters
05/09/2012EP2450446A2 Increasing levels of nicotinic alkaloids
05/09/2012EP2450445A1 Mutant G-protein coupled receptor with increased conformational stability
05/09/2012EP2450442A1 Compositions and methods of using chondroitinase abci mutants
05/09/2012EP2450440A1 Fibrinogenolytic enzyme tabfiblysin of horsefly, tabanus yao, encoding gene and use thereof
05/09/2012EP2450438A1 Cellulase preparation containing endoglucanases derived from two different types of microorganisms
05/09/2012EP2450437A2 Gene defects and mutant ALK kinase in human solid tumors
05/09/2012EP2450435A1 Maltotriocil transferase, process for production thereof, and use thereof
05/09/2012EP2450434A2 Process for the production of arachidonic acid and/or eicosapentaenoic acid
05/09/2012EP2450430A1 Bioassay method for antibody against thyroid-stimulating hormone receptor, measurement kit for the antibody, and novel genetically modified cell for use in the bioassay method or the measurement kit
05/09/2012EP2450381A1 Anti-RHD monoclonal antibodies
05/09/2012EP2450379A1 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
05/09/2012EP2450378A1 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
05/09/2012EP2450377A1 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
05/09/2012EP2450376A2 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
05/09/2012EP2450373A2 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
05/09/2012EP2450032A2 Microvesicles derived from nucleated, mammalian cells and use thereof
05/09/2012EP2449135A1 Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
05/09/2012EP2449115A2 Methods and kits for high efficiency engineering of conditional mouse alleles
05/09/2012EP2449114A1 Novel lipid formulations for delivery of therapeutic agents to solid tumors
05/09/2012EP2449113A1 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
05/09/2012EP2449112A1 Genetically modified rat models for severe combined immunodeficiency (scid)
05/09/2012EP2449111A2 Expression of transcription regulators that provide heat tolerance